Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy
Authors:
- Stefan BrunnerStefan Brunner
- Andrei TodicaAndrei Todica
- Guido BöningGuido Böning
- Stefan G NekollaStefan G Nekolla
- Moritz WildgruberMoritz Wildgruber
- Sebastian LehnerSebastian Lehner
- Martina SauterMartina Sauter
- Christopher ÜbleisChristopher Übleis
- Karin KlingelKarin Klingel
- Paul CummingPaul Cumming
- Wolfgang Michael FranzWolfgang Michael Franz
- Marcus HackerMarcus Hacker
Open Access
- 3 August 2012
- journal article
- Published by Springer Nature in EJNMMI Research
- Vol. 2 (1) , 43
Abstract
Background: We performed an initial evaluation of non-invasive ECG-gated [18 F]FDG-positron emission tomography (FDG-PET) for serial measurements of left ventricular volumes and function in murine models of dilated (DCM) and ischemic cardiomyopathy (ICM), and then tested the effect of erythropoietin (EPO) treatment on DCM mice in a preliminary FDG-PET therapy monitoring study. Methods: Mice developed DCM 8 weeks after injection with Coxsackievirus B3 (CVB3), whereas ICM was induced by ligation of the left anterior descending artery. LV volumes (EDV and ESV) and the ejection fraction (LVEF) of DCM, ICM and healthy control mice were measured by FDG-PET and compared with reference standard results obtained with 1.5 T magnetic resonance imaging (MRI). In the subsequent monitoring study, LVEF of DCM mice was evaluated by FDG-PET at baseline, and after 4 weeks of treatment, with EPO or saline. Results: LV volumes and the LVEF as measured by FDG-PET correlated significantly with the MRI results. These correlations were higher in healthy and DCM mice than in ICM mice, in which LVEF measurements were somewhat compromised by absence of FDG uptake in the area of infarction. LV volumes (EDV and ESV) were systematically underestimated by FDG-PET, with net bias such that LVEF measurements in both models of heart disease exceeded by 15% to 20% results obtained by MRI. In our subsequent monitoring study of DCM mice, we found a significant decrease of LVEF in the EPO group, but not in the saline-treated mice. Moreover, LVEF in the EPO and saline mice significantly correlated with histological scores of fibrosis. Conclusions: LVEF estimated by ECG-gated FDG-PET significantly correlated with the reference standard MRI, most notably in healthy mice and mice with DCM. FDG-PET served for longitudinal monitoring of effects of EPO treatment in DCM mice.Keywords
This publication has 36 references indexed in Scilit:
- Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial InfarctionJAMA, 2011
- A single dose of erythropoietin in ST-elevation myocardial infarctionEuropean Heart Journal, 2010
- Imaging Myocardial Metabolic RemodelingJournal of Nuclear Medicine, 2010
- Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial InfarctionCirculation Journal, 2010
- Quantification of Left Ventricular Volumes and Ejection Fraction in Mice Using PET, Compared with MRIJournal of Nuclear Medicine, 2008
- Erythropoietin Attenuates the Development of Experimental Autoimmune MyocarditisCardiovascular Drugs and Therapy, 2007
- Sustained Nitric Oxide Synthesis Contributes to Immunopathology in Ongoing Myocarditis Attributable to Interleukin-10 DisordersThe American Journal of Pathology, 2006
- Cardioprotective effects of recombinant human erythropoietin in rats with experimental autoimmune myocarditisBiochemical and Biophysical Research Communications, 2006
- Clinical validation of the gated blood pool SPECT QBS® processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiographyThe International Journal of Cardiovascular Imaging, 2005
- Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and phosphatidylinositol 3‐kinase signalingThe FASEB Journal, 2005